• In 2001, Questcor Pharmaceuticals bought the rights to make Acthar Gel, a hormone injection to treat a rare form of infantile epilepsy, and gradually raised the price from $40 a vial to $28,000 a vial. The British company Mallinckrodt bought Questcor in 2014 and apparently figured the vials were still too cheap, raising the price to $34,000. However, the Federal Trade Commission noticed that Mallinckrodt also during the latter period bought out -- and closed down -- the only company manufacturing a similar, cheaper version of the product, thus ensuring that Mallinckrodt had totally cornered the market. In January, the FTC announced that Mallinckrodt agreed to a $100 million settlement of the agency's charge of illegal anti-competitive practices. ("$100 million" is only slightly more than the price of giving one vial to each infant expected to need it in the next year.) [Futurism, 1-18-2017]
• TPrecocious: Girl Scout Charlotte McCourt, 11, of South Orange, New Jersey, saw her sales zoom recently when she posted "brutally honest" reviews of the Scouts' cookies she was selling -- giving none of them a "10" and labeling some with dour descriptions. She was hoping to sell 300 boxes, but as of the end of January, had registered 16,430. For the record, the best cookie was -- of course -- the Samoa, rated 9, but longtime favorites like the Trefoil ("boring") rated 6 and the Do-Si-Do ("bland") 5. The new Toffee-tastic was simply a "bleak, flavorless, gluten-free wasteland." [NJ.com, 1-31-2017]
Contact The Editor
Articles By This Author